- Article metrics
- Last updated: Sat, 21 Feb 2026 20:24:14 Z
Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma
Access & Citations
-
- 5933
- Article Accesses
-
- 9
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
